Evidence map›Paper›PMID 31223507›Full record

ArticleCase reports in endocrinology2019

HDR Syndrome Accompanying Type 1 Diabetes Mellitus and Hypopituitarism.

Mustafa Can, Feridun Karakurt, Muhammed Kocabas, İlker Cordan, Melia Karakose, Mustafa Kulaksızoglu

Abstract readCase Reports
In one paragraph

Article in Case reports in endocrinology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mustafa CanDepartment of Endocrinology and Metabolism, Meram School of Medicine, Necmettin Erbakan University, Konya, Turkey.ORCID 0000-0003-3241-4104
Feridun KarakurtDepartment of Endocrinology and Metabolism, Meram School of Medicine, Necmettin Erbakan University, Konya, Turkey.
Muhammed KocabasDepartment of Endocrinology and Metabolism, Meram School of Medicine, Necmettin Erbakan University, Konya, Turkey.
İlker CordanDepartment of Endocrinology and Metabolism, Meram School of Medicine, Necmettin Erbakan University, Konya, Turkey.
Melia KarakoseDepartment of Endocrinology and Metabolism, Meram School of Medicine, Necmettin Erbakan University, Konya, Turkey.
Mustafa KulaksızogluDepartment of Endocrinology and Metabolism, Meram School of Medicine, Necmettin Erbakan University, Konya, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

HDR (Hypoparathyroidism, Deafness, and Renal Dysplasia) syndrome is an autosomal dominant disorder characterized by the triad of hypoparathyroidism, sensorineural deafness, and renal disease. Approximately 65% of patients with HDR syndrome have all three of these features, while others have different combinations of these features. We aimed to present a case with primary hypoparathyroidism, hearing loss, and nondiabetic chronic kidney disease and diagnosed as HDR syndrome while being followed up for type 1 diabetes mellitus and hypopituitarism.

Identifiers

PMID31223507
PMCPMC6541993

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.